Literature DB >> 15880497

Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: the role of stroma cells in tumor angiogenesis.

Assaf A Gilad1, Tomer Israely, Hagit Dafni, Gila Meir, Batya Cohen, Michal Neeman.   

Abstract

Maintaining homogeneous perfusion in tissues undergoing remodeling and vascular expansion requires tight orchestration of the signals leading to endothelial sprouting and subsequent recruitment of perivascular contractile cells and vascular maturation. This regulation, however, is frequently disrupted in tumors. We previously demonstrated the role of tumor-associated myofibroblasts in vascularization and exit from dormancy of human ovarian carcinoma xenografts in nude mice. The aim of this work was to determine the contribution of stroma- and tumor cell-derived angiogenic growth factors to the heterogeneity of vascular permeability and maturation in MLS human ovarian carcinoma tumors. We show by RT-PCR and by in situ hybridization that VEGF was expressed by the tumor cells, while angiopoietin-1 and -2 were expressed only by the infiltrating host stroma cells. Vascular maturation was detected in vivo by vasoreactivity to hypercapnia, measured by BOLD contrast MRI and validated by immunostaining of histologic sections to alpha-smooth muscle actin. Vascular permeability was measured in vivo by dynamic contrast-enhanced MRI using albumin-based contrast material and validated in histologic sections by fluorescent staining of the biotinylated contrast material. MRI as well as histologic correlation maps between vascular maturation and vascular permeability revealed a wide range of vascular phenotypes, in which the distribution of vascular maturation and vasoreactivity did not overlap spatially with reduced permeability. The large heterogeneity in the degree of vascular maturation and permeability is consistent with the differential expression pattern of VEGF and angiopoietins during tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880497     DOI: 10.1002/ijc.21179

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Expression of the vascular endothelial growth factor and angiopoietins in mucoepidermoid carcinoma of salivary gland.

Authors:  Ana P D Demasi; Carolina A B Silva; Alessandra D Silva; Cristiane Furuse; Andresa B Soares; Albina Altemani; Marcelo H Napimoga; Vera C Araújo
Journal:  Head Neck Pathol       Date:  2011-09-25

2.  Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.

Authors:  Stefan A Carp; Amir Y Sajjadi; Christy M Wanyo; Qianqian Fang; Michelle C Specht; Lidia Schapira; Beverly Moy; Aditya Bardia; David A Boas; Steven J Isakoff
Journal:  Biomed Opt Express       Date:  2013-11-22       Impact factor: 3.732

3.  Inspired gas-induced vascular change in tumors with magnetic-resonance-guided near-infrared imaging: human breast pilot study.

Authors:  Colin M Carpenter; Rebecca Rakow-Penner; Shudong Jiang; Bruce L Daniel; Brian W Pogue; Gary H Glover; Keith D Paulsen
Journal:  J Biomed Opt       Date:  2010 May-Jun       Impact factor: 3.170

Review 4.  Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis.

Authors:  Reut Avni; Batya Cohen; Michal Neeman
Journal:  NMR Biomed       Date:  2011-01-17       Impact factor: 4.044

5.  Analysing the response in R2* relaxation rate of intracranial tumours to hyperoxic and hypercapnic respiratory challenges: initial results.

Authors:  A Müller; S Remmele; I Wenningmann; H Clusmann; F Träber; S Flacke; R König; J Gieseke; W A Willinek; H H Schild; P Mürtz
Journal:  Eur Radiol       Date:  2010-09-22       Impact factor: 5.315

6.  Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.

Authors:  Hanna Sallinen; Maarit Anttila; Johanna Narvainen; Jonna Koponen; Kirsi Hamalainen; Ivana Kholova; Tommi Heikura; Pyry Toivanen; Veli-Matti Kosma; Seppo Heinonen; Kari Alitalo; Seppo Yla-Herttuala
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

7.  Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.

Authors:  Rotem S Lanzman; Phil M Robson; Maryellen R Sun; Amish D Patel; Kimiknu Mentore; Andrew A Wagner; Elizabeth M Genega; Neil M Rofsky; David C Alsop; Ivan Pedrosa
Journal:  Radiology       Date:  2012-10-09       Impact factor: 11.105

Review 8.  Fibroblasts as architects of cancer pathogenesis.

Authors:  Timothy Marsh; Kristian Pietras; Sandra S McAllister
Journal:  Biochim Biophys Acta       Date:  2012-10-30

9.  Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media.

Authors:  Helena Sheikhet Migalovich; Vyacheslav Kalchenko; Nava Nevo; Gila Meir; Fortune Kohen; Michal Neeman
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

10.  In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors.

Authors:  Dorit Granot; Yoseph Addadi; Vyacheslav Kalchenko; Alon Harmelin; Leoni A Kunz-Schughart; Michal Neeman
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.